Skip to main content

Day: January 22, 2024

Form 8.3 – [LXi REIT PLC – 19 01 2024] – CGWL

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LXi REIT PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

The Board of Director’s decision to issue convertible loans

        The Board of Director’s decision to issue convertible loans    22 January 2024Company Announcement no. 01   The Board of Directors in Phama Equity Group has decided to issue convertible loans in accordance with the authorisation in the company’s articles of association under article 4.3.A. The convertible loans allow Phama Equity Group to borrow up to DKK 8.914.795. The main terms of the convertible loans are: The loan is granted as subordinated loan capital and is therefore subordinated to the company’s other creditors, except for any other corresponding subordinated loan capital. The lenders right to convert the loan into shares in in the company may be exercised for a period of 30 days commencing 23 calendar months after the conclusion of the convertible loan (“the Exercise Period”). The...

Continue reading

Acrylonitrile Butadiene Styrene Resin Market Size Worth USD 33.1 Billion in 2032 | Emergen Research

Rising adoption of ABS in the automobile and medical industries and rapid growth of the construction sector globally are key factors driving Acrylonitrile Butadiene Styrene (ABS) Resin Market revenue growth Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) — The global Acrylonitrile Butadiene Styrene (ABS) resin market size was USD 21.0 Billion in 2022 and is expected to register a rapid revenue CAGR of 4.7% during the forecast period. Rising adoption of ABS in the automobile and medical industries and rapid growth of the construction sector globally are key factors driving market revenue growth. ABS is a rigid thermoplastic polymer, which has properties such as flexibility, resilience to temperature, and good appearance. These materials have major applications in electronic appliances and automotive sectors where these are used for vehicles...

Continue reading

Endeavor Bancorp Reports Net Income of $852,000 for the Fourth Quarter of 2023; Results Highlighted by Strong Loan Growth and Increasing Asset Yields

SAN DIEGO, Jan. 22, 2024 (GLOBE NEWSWIRE) —  Endeavor Bancorp (OTCQX: EDVR) (the “Company,” or “Bancorp”), the holding company for Endeavor Bank (the “Bank”), today announced net income of $852 thousand, or $0.20 per diluted share, for the fourth quarter of 2023, down from net income of $1.2 million, or $0.29 per diluted share, for the third quarter of 2023, and up from $764 thousand, or $0.19 per diluted share, for the fourth quarter of 2022. Core earnings, which excludes PPP fee income and loan loss provision expense, for the year ending December 31, 2023 was $6.6 million, compared to $4.9 million in 2022 for an increase of 34.7%. Strong core earnings were driven by higher rates on earning assets, as interest income on loans increased $6.6 million and interest income on bank deposits and investments increased $5.0 million for...

Continue reading

Diana Shipping Inc. Announces Expansion of Previously Announced Joint Venture for Offshore Wind Service Vessels

ATHENS, Greece, Jan. 22, 2024 (GLOBE NEWSWIRE) —  Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that its previously announced joint venture (“Windward Offshore”) with Blue Star Group GmbH & Cie. KG, SeaRenergy Offshore Holding GmbH and SeraVerse GmbH to purchase offshore wind service vessels (“CSOVs”) has excercised its option to acquire two additional newbuilding CSOVs from VARD. Following the completion of the acquisition of the two additional CSOVs, the Windward Offshore will have contracts to acquire four CSOVs, with deliveries scheduled to occur between the third quarter of 2025 and the third quarter of 2026. Diana Shipping Inc.’s fleet currently consists of 40 dry bulk vessels: 4 Newcastlemax, 9 Capesize,...

Continue reading

Oatly Announces Sweet Collaboration with Carvel®, One of America’s Most Beloved Ice Cream Destinations

A New Twist on a Cold Classic: Oatly Non-Dairy Frozen Desserts Roll Out as Carvel’s First Oatmilk-Based Menu Items Available In-ShoppeOatly Announces Sweet Collaboration with Carvel®A New Twist on a Cold Classic: Oatly Non-Dairy Frozen Desserts Roll Out as Carvel’s First Oatmilk-Based Menu Items Available In-ShoppeOatly Announces Sweet Collaboration with Carvel®A New Twist on a Cold Classic: Oatly Non-Dairy Frozen Desserts Roll Out as Carvel’s First Oatmilk-Based Menu Items Available In-ShoppeMALMÖ, Sweden, Jan. 22, 2024 (GLOBE NEWSWIRE) —  Oatly Group AB (Nasdaq: OTLY)(“Oatly” or the “Company”), the world’s original and largest oatmilk company, today announced a new national partnership with Carvel®, the cult classic ice cream shoppe best known for its soft serve and character cakes. Oatly’s non-dairy frozen...

Continue reading

DGP Plc Takes Drug Testing In-house with Fingerprint Sweat-based Testing

Construction logistics, security, and support specialist selects Intelligent Fingerprinting Drug Screening System to simplify and speed up workplace drug testing for its 450 employees and contractors “By using fingerprint drug testing, I no longer have to take people off a project for half a day for screening – we can conduct the tests there and then” – Ruth Trant, SHEQ & Assurance Director, DGP Plc NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that DGP Plc has selected the revolutionary portable Intelligent Fingerprinting Drug Screening System to enable in-house drug testing. DGP is one of the UK’s leading construction logistics, security and support...

Continue reading

Doré Copper Increases Size of its Joe Mann Property by Acquiring a 65% Interest in 3,030 Hectares

Figure 1. Joe Mann Property – Land Tenure Map and Main Gold OccurrencesJoe Mann Property – Land Tenure Map and Main Gold OccurrencesFigure 2. South Chibougamau Area – Land Tenure MapSouth Chibougamau Area – Land Tenure MapTORONTO, Jan. 22, 2024 (GLOBE NEWSWIRE) — Doré Copper Mining Corp. (the “Company” or “Doré Copper“) (TSXV: DCMC; OTCQX: DRCMF; FRA: DCM) is pleased to announce that it has exercised its right to acquire a 65% interest in certain claims subject to a joint venture with SOQUEM (the “SOQUEM JV Property“), which surround and are adjacent to the Company’s 100% owned Joe Mann Property, pursuant to an earn-in option agreement (the “Option Agreement“) dated January 2, 2020, as amended October 28, 2022, between the Company and...

Continue reading

FLUENT Opens 34th Medical Cannabis Dispensary in Cocoa, Florida; 37th Nationwide

TAMPA, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) — Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, announced the opening of its 34th medical cannabis dispensary in Florida and 37th retail location nationwide. FLUENT Cocoa is located at 941 N Cocoa Blvd, Cocoa, FL 32922. The new 2,600 square foot dispensary is the first dispensary in Cocoa with a cannabis drive-thru which will increase accessibility, improve service speed and provide the utmost discretion for patients. The dispensary was built out with local contractors and will provide over $400 thousand in annual wages for local employees, and an estimated $3.5 million total benefit to the local economy. The dispensary will offer promotional specials during...

Continue reading

Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024

Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024 CARDIFF, United Kingdom, Jan. 22, 2024 (GLOBE NEWSWIRE) – Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs including Type 1 diabetes and rare / orphan brain cancers, today announced that Stephen Stamp, CEO and CFO of Biodexa, has issued a Shareholder Letter highlighting the Company’s progress in 2023 and expected milestones in 2024. The full text of the letter follows: Dear Shareholders, I thought now would be a good time to review our Company’s progress in 2023 and our plans and expected milestones for 2024, the latter being set out in the following...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.